<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33499374</PMID><DateCompleted><Year>2021</Year><Month>10</Month><Day>12</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>12</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2073-4409</ISSN><JournalIssue CitedMedium="Internet"><Volume>10</Volume><Issue>2</Issue><PubDate><Year>2021</Year><Month>Jan</Month><Day>22</Day></PubDate></JournalIssue><Title>Cells</Title><ISOAbbreviation>Cells</ISOAbbreviation></Journal><ArticleTitle>TDP-43 Regulation of AChE Expression Can Mediate ALS-Like Phenotype in Zebrafish.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">221</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/cells10020221</ELocationID><Abstract><AbstractText>The "distal axonopathy" hypothesis in amyotrophic lateral sclerosis (ALS) proposes that pathological changes occur at the neuromuscular junction (NMJ) early in the disease. While acetylcholinesterase (AChE) plays an important role in the functionality of the NMJ, its potential role in ALS remains unexplored. Here, we identified AChE as a limiting factor regulating muscle/motor neuron connection in a vertebrate model of ALS. Knockdown of the TAR DNA-binding protein 43 (TDP-43) orthologue in zebrafish resulted in early defects of motor functions coupled with NMJ disassembly. We found that a partially depleted tdp-43 caused a decrease of ache expression. Importantly, human AChE overexpression reduced the phenotypic defects in the tdp-43 loss of function model, with amelioration of post- and pre-synaptic deficits at the NMJ. In conclusion, our results provide a better understanding of the role of TDP-43 in the NMJ organization and indicate AChE as a contributing factor in the pathology of ALS. In particular, it may be implicated in the early defects that characterize NMJs in this major neurodegenerative disorder.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Campanari</LastName><ForeName>Maria-Letizia</ForeName><Initials>ML</Initials><AffiliationInfo><Affiliation>Team "Translational Research for Neuronlogical Diseases", Institut Imagine Inserm U1163, Universit&#xe9; de Paris; Sorbonne Universit&#xe9;, Universit&#xe9; Pierre et Marie Curie (UPMC), Universit&#xe9; de Paris 06, Unit&#xe9; Mixte 75, Institut National de la Sant&#xe9; et de la Recherche M&#xe9;dicale (INSERM) Unit&#xe9; 1127, Centre National de la Recherche Scientifique (CNRS) Unit&#xe9; Mixte de Recherche 7225 Institut du Cerveau et de la Moelle &#xc9;pini&#xe8;re (ICM), 75013 Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marian</LastName><ForeName>Anca</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Team "Translational Research for Neuronlogical Diseases", Institut Imagine Inserm U1163, Universit&#xe9; de Paris; Sorbonne Universit&#xe9;, Universit&#xe9; Pierre et Marie Curie (UPMC), Universit&#xe9; de Paris 06, Unit&#xe9; Mixte 75, Institut National de la Sant&#xe9; et de la Recherche M&#xe9;dicale (INSERM) Unit&#xe9; 1127, Centre National de la Recherche Scientifique (CNRS) Unit&#xe9; Mixte de Recherche 7225 Institut du Cerveau et de la Moelle &#xc9;pini&#xe8;re (ICM), 75013 Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ciura</LastName><ForeName>Sorana</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Team "Translational Research for Neuronlogical Diseases", Institut Imagine Inserm U1163, Universit&#xe9; de Paris; Sorbonne Universit&#xe9;, Universit&#xe9; Pierre et Marie Curie (UPMC), Universit&#xe9; de Paris 06, Unit&#xe9; Mixte 75, Institut National de la Sant&#xe9; et de la Recherche M&#xe9;dicale (INSERM) Unit&#xe9; 1127, Centre National de la Recherche Scientifique (CNRS) Unit&#xe9; Mixte de Recherche 7225 Institut du Cerveau et de la Moelle &#xc9;pini&#xe8;re (ICM), 75013 Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kabashi</LastName><ForeName>Edor</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0003-4118-251X</Identifier><AffiliationInfo><Affiliation>Team "Translational Research for Neuronlogical Diseases", Institut Imagine Inserm U1163, Universit&#xe9; de Paris; Sorbonne Universit&#xe9;, Universit&#xe9; Pierre et Marie Curie (UPMC), Universit&#xe9; de Paris 06, Unit&#xe9; Mixte 75, Institut National de la Sant&#xe9; et de la Recherche M&#xe9;dicale (INSERM) Unit&#xe9; 1127, Centre National de la Recherche Scientifique (CNRS) Unit&#xe9; Mixte de Recherche 7225 Institut du Cerveau et de la Moelle &#xc9;pini&#xe8;re (ICM), 75013 Paris, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>1</GrantID><Acronym>CX</Acronym><Agency>CSRD VA</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>01</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Cells</MedlineTA><NlmUniqueID>101600052</NlmUniqueID><ISSNLinking>2073-4409</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C585345">Tardbp protein, zebrafish</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D029961">Zebrafish Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.1.1.7</RegistryNumber><NameOfSubstance UI="D000110">Acetylcholinesterase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000110" MajorTopicYN="N">Acetylcholinesterase</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004843" MajorTopicYN="N">Epistasis, Genetic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055785" MajorTopicYN="N">Gene Knockdown Techniques</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009469" MajorTopicYN="N">Neuromuscular Junction</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011485" MajorTopicYN="N">Protein Binding</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015027" MajorTopicYN="N">Zebrafish</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029961" MajorTopicYN="N">Zebrafish Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">TAR DNA-binding protein 43 (TDP-43)</Keyword><Keyword MajorTopicYN="N">acetylcholinesterase (AChE)</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis (ALS)</Keyword><Keyword MajorTopicYN="N">knockdown (KD)</Keyword><Keyword MajorTopicYN="N">neuromuscular junction (NMJ)</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>10</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>1</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>1</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>1</Month><Day>27</Day><Hour>1</Hour><Minute>9</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>1</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>10</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33499374</ArticleId><ArticleId IdType="pmc">PMC7911940</ArticleId><ArticleId IdType="doi">10.3390/cells10020221</ArticleId><ArticleId IdType="pii">cells10020221</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Taylor J.P., Brown R.H., Cleveland D.W. Decoding ALS: From genes to mechanism. Nature. 2016;539:197&#x2013;206. doi: 10.1038/nature20413.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature20413</ArticleId><ArticleId IdType="pmc">PMC5585017</ArticleId><ArticleId IdType="pubmed">27830784</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M., Sampathu D.M., Kwong L.K., Truax A.C., Micsenyi M.C., Chou T.T., Bruce J., Schuck T., Grossman M., Clark C.M., et al. Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis. Science. 2006;314:130&#x2013;133. doi: 10.1126/science.1134108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1134108</ArticleId><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Arai T., Hasegawa M., Akiyama H., Ikeda K., Nonaka T., Mori H., Mann D., Tsuchiya K., Yoshida M., Hashizume Y., et al. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem. Biophys. Res. Commun. 2006;351:602&#x2013;611. doi: 10.1016/j.bbrc.2006.10.093.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2006.10.093</ArticleId><ArticleId IdType="pubmed">17084815</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie I.R., Rademakers R., Neumann M. TDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia. Lancet Neurol. 2010;9:995&#x2013;1007. doi: 10.1016/S1474-4422(10)70195-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(10)70195-2</ArticleId><ArticleId IdType="pubmed">20864052</ArticleId></ArticleIdList></Reference><Reference><Citation>Kabashi E., Valdmanis P.N., Dion P., Spiegelman D., McConkey B.J., Vande Velde C., Bouchard J.P., Lacomblez L., Pochigaeva K., Salachas F., et al. TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Nat. Genet. 2008;40:572&#x2013;574. doi: 10.1038/ng.132.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.132</ArticleId><ArticleId IdType="pubmed">18372902</ArticleId></ArticleIdList></Reference><Reference><Citation>Sreedharan J., Blair I.P., Tripathi V.B., Hu X., Vance C., Rogelj B., Ackerley S., Durnall J.C., Williams K.L., Buratti E., et al. TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science. 2008;319:1668&#x2013;1672. doi: 10.1126/science.1154584.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1154584</ArticleId><ArticleId IdType="pmc">PMC7116650</ArticleId><ArticleId IdType="pubmed">18309045</ArticleId></ArticleIdList></Reference><Reference><Citation>Krecic A.M., Swanson M.S. hnRNP complexes: Composition, structure, and function. Curr. Opin. Cell Biol. 1999;11:363&#x2013;371. doi: 10.1016/S0955-0674(99)80051-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0955-0674(99)80051-9</ArticleId><ArticleId IdType="pubmed">10395553</ArticleId></ArticleIdList></Reference><Reference><Citation>Buratti E., Brindisi A., Giombi M., Tisminetzky S., Ayala Y.M., Baralle F.E. TDP-43 binds heterogeneous nuclear ribonucleoprotein A/B through its C-terminal tail: An important region for the inhibition of cystic fibrosis transmembrane conductance regulator exon 9 splicing. J. Biol. Chem. 2005;280:37572&#x2013;37584. doi: 10.1074/jbc.M505557200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M505557200</ArticleId><ArticleId IdType="pubmed">16157593</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling S.-C., Polymenidou M., Cleveland D.W. Converging Mechanisms in ALS and FTD: Disrupted RNA and Protein Homeostasis. Neuron. 2013;79:416&#x2013;438. doi: 10.1016/j.neuron.2013.07.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2013.07.033</ArticleId><ArticleId IdType="pmc">PMC4411085</ArticleId><ArticleId IdType="pubmed">23931993</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao M., Kim J.R., van Bruggen R., Park J. RNA-binding proteins in amyotrophic lateral sclerosis. Mol. Cells. 2018;41:818&#x2013;829.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6182225</ArticleId><ArticleId IdType="pubmed">30157547</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer L.R., Culver D.G., Tennant P., Davis A.A., Wang M., Castellano-Sanchez A., Khan J., Polak M.A., Glass J.D. Amyotrophic lateral sclerosis is a distal axonopathy: Evidence in mice and man. Exp. Neurol. 2004;185:232&#x2013;240. doi: 10.1016/j.expneurol.2003.10.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2003.10.004</ArticleId><ArticleId IdType="pubmed">14736504</ArticleId></ArticleIdList></Reference><Reference><Citation>Killian J.M., Wilfong A.A., Burnett L., Appel S.H., Boland D. Decremental motor responses to repetitive nerve stimulation in ALS. Muscle Nerve. 1994;17:747&#x2013;754. doi: 10.1002/mus.880170708.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.880170708</ArticleId><ArticleId IdType="pubmed">8008001</ArticleId></ArticleIdList></Reference><Reference><Citation>Clark J.A., Southam K.A., Blizzard C.A., King A.E., Dickson T.C. Axonal degeneration, distal collateral branching and neuromuscular junction architecture alterations occur prior to symptom onset in the SOD1G93A mouse model of amyotrophic lateral sclerosis. J. Chem. Neuroanat. 2016;76:35&#x2013;47. doi: 10.1016/j.jchemneu.2016.03.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jchemneu.2016.03.003</ArticleId><ArticleId IdType="pubmed">27038603</ArticleId></ArticleIdList></Reference><Reference><Citation>Campanari M.-L., Garc&#xed;a-Ayll&#xf3;n M.-S., Ciura S., S&#xe1;ez-Valero J., Kabashi E. Neuromuscular Junction Impairment in Amyotrophic Lateral Sclerosis: Reassessing the Role of Acetylcholinesterase. Front. Mol. Neurosci. 2016;9:160. doi: 10.3389/fnmol.2016.00160.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2016.00160</ArticleId><ArticleId IdType="pmc">PMC5187284</ArticleId><ArticleId IdType="pubmed">28082868</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor P., Radi&#x107; Z. The cholinesterases: From genes to proteins. Annu. Rev. Pharmacol. Toxicol. 1994;34:281&#x2013;320. doi: 10.1146/annurev.pa.34.040194.001433.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.pa.34.040194.001433</ArticleId><ArticleId IdType="pubmed">8042853</ArticleId></ArticleIdList></Reference><Reference><Citation>Massouli&#xe9; J. The origin of the molecular diversity and functional anchoring of cholinesterases. NeuroSignals. 2002;11:130&#x2013;143. doi: 10.1159/000065054.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000065054</ArticleId><ArticleId IdType="pubmed">12138250</ArticleId></ArticleIdList></Reference><Reference><Citation>Meshorer E., Toiber D., Zurel D., Sahly I., Dori A., Cagnano E., Schreiber L., Grisaru D., Tronche F., Soreq H. Combinatorial complexity of 5&#x2032; alternative acetylcholinesterase transcripts and protein products. J. Biol. Chem. 2004;279:29740&#x2013;29751. doi: 10.1074/jbc.M402752200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M402752200</ArticleId><ArticleId IdType="pubmed">15123727</ArticleId></ArticleIdList></Reference><Reference><Citation>Perrier A.L., Massouli&#xe9; J., Krejci E. PRiMA: The membrane anchor of acetylcholinesterase in the brain. Neuron. 2002;33:275&#x2013;285. doi: 10.1016/S0896-6273(01)00584-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0896-6273(01)00584-0</ArticleId><ArticleId IdType="pubmed">11804574</ArticleId></ArticleIdList></Reference><Reference><Citation>Sigoillot S.M., Bourgeois F., Lambergeon M., Strochlic L., Legay C. ColQ controls postsynaptic differentiation at the neuromuscular junction. J. Neurosci. 2010;30:13&#x2013;23. doi: 10.1523/JNEUROSCI.4374-09.2010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.4374-09.2010</ArticleId><ArticleId IdType="pmc">PMC6632527</ArticleId><ArticleId IdType="pubmed">20053883</ArticleId></ArticleIdList></Reference><Reference><Citation>Dudel J., Heckmann M. Desensitization reduces amplitudes of quantal end-plate currents after a single preceding end-plate current in mouse muscle. Pflugers Arch. Eur. J. Physiol. 1999;437:569&#x2013;576. doi: 10.1007/s004240050819.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s004240050819</ArticleId><ArticleId IdType="pubmed">10089570</ArticleId></ArticleIdList></Reference><Reference><Citation>Adler M., Manley H.A., Purcell A.L., Deshpande S.S., Hamilton T.A., Kan R.K., Oyler G., Lockridge O., Duysen E.G., Sheridan R.E. Reduced acetylcholine receptor density, morphological remodeling, and butyrylcholinesterase activity can sustain muscle function in acetylcholinesterase knockout mice. Muscle Nerve. 2004;30:317&#x2013;327. doi: 10.1002/mus.20099.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.20099</ArticleId><ArticleId IdType="pubmed">15318343</ArticleId></ArticleIdList></Reference><Reference><Citation>Misgeld T., Kummer T.T., Lichtman J.W., Sanes J.R. Agrin promotes synaptic differentiation by counteracting an inhibitory effect of neurotransmitter. Proc. Natl. Acad. Sci. USA. 2005;102:11088&#x2013;11093. doi: 10.1073/pnas.0504806102.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0504806102</ArticleId><ArticleId IdType="pmc">PMC1182450</ArticleId><ArticleId IdType="pubmed">16043708</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin W., Dominguez B., Yang J., Aryal P., Brandon E.P., Gage F.H., Lee K.-F. Neurotransmitter acetylcholine negatively regulates neuromuscular synapse formation by a Cdk5-dependent mechanism. Neuron. 2005;46:569&#x2013;579. doi: 10.1016/j.neuron.2005.04.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2005.04.002</ArticleId><ArticleId IdType="pubmed">15944126</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones S.A., Holmes C., Budd T.C., Greenfield S.A. The effect of acetylcholinesterase on outgrowth of dopaminergic neurons in organotypic slice culture of rat mid-brain. Cell Tissue Res. 1995;279:323&#x2013;330. doi: 10.1007/BF00318488.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF00318488</ArticleId><ArticleId IdType="pubmed">7895271</ArticleId></ArticleIdList></Reference><Reference><Citation>Srivatsan M., Peretz B. Acetylcholinesterase promotes regeneration of neurites in cultured adult neurons of Aplysia. Neuroscience. 1997;77:921&#x2013;931. doi: 10.1016/S0306-4522(96)00458-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0306-4522(96)00458-7</ArticleId><ArticleId IdType="pubmed">9070763</ArticleId></ArticleIdList></Reference><Reference><Citation>Dupree J.L., Bigbee J.W. Acetylcholinesterase inhibitor treatment delays recovery from axotomy in cultured dorsal root ganglion neurons. J. Neurocytol. 1996;25:439&#x2013;454. doi: 10.1007/BF02284814.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF02284814</ArticleId><ArticleId IdType="pubmed">8899566</ArticleId></ArticleIdList></Reference><Reference><Citation>Grisaru D., Sternfeld M., Eldor A., Glick D., Soreq H. Structural roles of acetylcholinesterase variants in biology and pathology. Eur. J. Biochem. 1999;264:672&#x2013;686. doi: 10.1046/j.1432-1327.1999.00693.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1432-1327.1999.00693.x</ArticleId><ArticleId IdType="pubmed">10491113</ArticleId></ArticleIdList></Reference><Reference><Citation>Sternfeld M., Ming G.L., Song H.J., Sela K., Timberg R., Poo M.M., Soreq H. Acetylcholinesterase enhances neurite growth and synapse development through alternative contributions of its hydrolytic capacity, core protein, and variable C termini. J. Neurosci. 1998;18:1240&#x2013;1249. doi: 10.1523/JNEUROSCI.18-04-01240.1998.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.18-04-01240.1998</ArticleId><ArticleId IdType="pmc">PMC6792736</ArticleId><ArticleId IdType="pubmed">9454834</ArticleId></ArticleIdList></Reference><Reference><Citation>Girard E., Bernard V., Camp S., Taylor P., Krejci E., Molg&#xf3; J. Remodeling of the Neuromuscular Junction in Mice with Deleted Exons 5 and 6 of Acetylcholinesterase. J. Mol. Neurosci. 2006;99 doi: 10.1385/JMN:30:1:99.</Citation><ArticleIdList><ArticleId IdType="doi">10.1385/JMN:30:1:99</ArticleId><ArticleId IdType="pubmed">17192646</ArticleId></ArticleIdList></Reference><Reference><Citation>Andres C., Beeri R., Friedman A., Lev-Lehman E., Henis S., Timberg R., Shani M., Soreq H. Acetylcholinesterase-transgenic mice display embryonic modulations in spinal cord choline acetyltransferase and neurexin I&#x3b2; gene expression followed by late-onset neuromotor deterioration. Proc. Natl. Acad. Sci. USA. 1997;94:8173&#x2013;8178. doi: 10.1073/pnas.94.15.8173.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.94.15.8173</ArticleId><ArticleId IdType="pmc">PMC21576</ArticleId><ArticleId IdType="pubmed">9223334</ArticleId></ArticleIdList></Reference><Reference><Citation>Andres C., Seidman S., Beeri R., Timberg R., Soreq H. Transgenic acetylcholinesterase induces enlargement of murine neuromuscular junctions but leaves spinal cord synapses intact. Neurochem. Int. 1998;32:449&#x2013;456. doi: 10.1016/S0197-0186(97)00121-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0197-0186(97)00121-6</ArticleId><ArticleId IdType="pubmed">9676744</ArticleId></ArticleIdList></Reference><Reference><Citation>Darvesh S., Hopkins D.A., Geula C. Neurobiology of butyrylcholinesterase. Nat. Rev. Neurosci. 2003;4:131&#x2013;138. doi: 10.1038/nrn1035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn1035</ArticleId><ArticleId IdType="pubmed">12563284</ArticleId></ArticleIdList></Reference><Reference><Citation>Darreh-Shori T., Soininen H. Effects of Cholinesterase Inhibitors on the Activities and Protein Levels of Cholinesterases in the Cerebrospinal Fluid of Patients with Alzheimers Disease: A Review of Recent Clinical Studies. Curr. Alzheimer Res. 2010;7:67&#x2013;73. doi: 10.2174/156720510790274455.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/156720510790274455</ArticleId><ArticleId IdType="pubmed">20205672</ArticleId></ArticleIdList></Reference><Reference><Citation>Bertrand C., Chatonnet A., Takke C., Yan Y.L., Postlethwait J., Toutant J.P., Cousin X. Zebrafish acetylcholinesterase is encoded by a single gene localized on linkage group 7. Gene structure and polymorphism; molecular forms and expression pattern during development. J. Biol. Chem. 2001;276:464&#x2013;474. doi: 10.1074/jbc.M006308200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M006308200</ArticleId><ArticleId IdType="pubmed">11016933</ArticleId></ArticleIdList></Reference><Reference><Citation>Behra M., Cousin X., Bertrand C., Vonesch J.L., Biellmann D., Chatonnet A., Str&#xe4;hle U. Acetylcholinesterase is required for neuronal and muscular development in the zebrafish embryo. Nat. Neurosci. 2002;5:111&#x2013;118. doi: 10.1038/nn788.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn788</ArticleId><ArticleId IdType="pubmed">11753420</ArticleId></ArticleIdList></Reference><Reference><Citation>Downes G.B., Granato M. Acetylcholinesterase function is dispensable for sensory neurite growth but is critical for neuromuscular synapse stability. Dev. Biol. 2004;270:232&#x2013;245. doi: 10.1016/j.ydbio.2004.02.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ydbio.2004.02.027</ArticleId><ArticleId IdType="pubmed">15136152</ArticleId></ArticleIdList></Reference><Reference><Citation>Festoff B.W., Fernandez H.L. Plasma and red blood cell acetylcholinesterase in amyotrophic lateral sclerosis. Muscle Nerve. 1981;4:41&#x2013;47. doi: 10.1002/mus.880040108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.880040108</ArticleId><ArticleId IdType="pubmed">7231444</ArticleId></ArticleIdList></Reference><Reference><Citation>Barry W. Festoff Release of Acetylcholinesterase in Amyotrophic lateral Sclerosis. Adv. Neurol. 1982;36:503.</Citation><ArticleIdList><ArticleId IdType="pubmed">6184970</ArticleId></ArticleIdList></Reference><Reference><Citation>Streichert L.C., Sargent P.B. The role of acetylcholinesterase in denervation supersensitivity in the frog cardiac ganglion. J. Physiol. 1992;445:249&#x2013;260. doi: 10.1113/jphysiol.1992.sp018922.</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/jphysiol.1992.sp018922</ArticleId><ArticleId IdType="pmc">PMC1179980</ArticleId><ArticleId IdType="pubmed">1501134</ArticleId></ArticleIdList></Reference><Reference><Citation>Marc G., Leah R., Ofira E., Oded A., Zohar A., Hanna R. Presymptomatic treatment with acetylcholinesterase antisense oligonucleotides prolongs survival in ALS (G93A-SOD1) mice. Biomed. Res. Int. 2013;2013 doi: 10.1155/2013/845345.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2013/845345</ArticleId><ArticleId IdType="pmc">PMC3881454</ArticleId><ArticleId IdType="pubmed">24455732</ArticleId></ArticleIdList></Reference><Reference><Citation>Maniatis S., &#xc4;ij&#xf6; T., Vickovic S., Braine C., Kang K., Mollbrink A., Fagegaltier D., Andrusivov&#xe1; &#x17d;., Saarenp&#xe4;&#xe4; S., Saiz-Castro G., et al. Spatiotemporal dynamics of molecular pathology in amyotrophic lateral sclerosis. Science. 2019;364:89&#x2013;93. doi: 10.1126/science.aav9776.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aav9776</ArticleId><ArticleId IdType="pubmed">30948552</ArticleId></ArticleIdList></Reference><Reference><Citation>Kabashi E., Lin L., Tradewell M.L., Dion P.A., Bercier V., Bourgouin P., Rochefort D., Bel Hadj S., Durham H.D., Vande Velde C., et al. Gain and loss of function of ALS-related mutations of TARDBP (TDP-43) cause motor deficits in vivo. Hum. Mol. Genet. 2009;19:671&#x2013;683. doi: 10.1093/hmg/ddp534.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddp534</ArticleId><ArticleId IdType="pubmed">19959528</ArticleId></ArticleIdList></Reference><Reference><Citation>Parichy D.M., Elizondo M.R., Mills M.G., Gordon T.N., Engeszer R.E. Normal table of postembryonic zebrafish development: Staging by externally visible anatomy of the living fish. Dev. Dyn. 2009;238:2975&#x2013;3015. doi: 10.1002/dvdy.22113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/dvdy.22113</ArticleId><ArticleId IdType="pmc">PMC3030279</ArticleId><ArticleId IdType="pubmed">19891001</ArticleId></ArticleIdList></Reference><Reference><Citation>Kimmel C.B., Ballard W.W., Kimmel S.R., Ullmann B., Schilling T.F. Stages of embryonic development of the zebrafish. Dev. Dyn. 1995;203:253&#x2013;310. doi: 10.1002/aja.1002030302.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/aja.1002030302</ArticleId><ArticleId IdType="pubmed">8589427</ArticleId></ArticleIdList></Reference><Reference><Citation>Campanari M.-L., Garc&#xed;a-Ayll&#xf3;n M.-S., Belbin O., Galcer&#xe1;n J., Lle&#xf3; A., S&#xe1;ez-Valero J. Acetylcholinesterase modulates presenilin-1 levels and &#x3b3;-secretase activity. J. Alzheimers. Dis. 2014;41 doi: 10.3233/JAD-140426.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-140426</ArticleId><ArticleId IdType="pubmed">24699279</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciura S., Lattante S., Le Ber I., Latouche M., Tostivint H., Brice A., Kabashi E. Loss of function of C9orf72 causes motor deficits in a zebrafish model of amyotrophic lateral sclerosis. Ann. Neurol. 2013;74:180&#x2013;187. doi: 10.1002/ana.23946.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.23946</ArticleId><ArticleId IdType="pubmed">23720273</ArticleId></ArticleIdList></Reference><Reference><Citation>S&#xe1;ez-Valero J., Tornel P.L., Mu&#xf1;oz-Delgado E., Vidal C.J. Amphiphilic and hydrophilic forms of acetyl- and butyrylcholinesterase in human brain. J. Neurosci. Res. 1993;35:678&#x2013;689. doi: 10.1002/jnr.490350610.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jnr.490350610</ArticleId><ArticleId IdType="pubmed">8411269</ArticleId></ArticleIdList></Reference><Reference><Citation>Lemmens R., Van Hoecke A., Hersmus N., Geelen V., D&#x2019;Hollander I., Thijs V., Van Den Bosch L., Carmeliet P., Robberecht W. Overexpression of mutant superoxide dismutase 1 causes a motor axonopathy in the zebrafish. Hum. Mol. Genet. 2007;16:2359&#x2013;2365. doi: 10.1093/hmg/ddm193.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddm193</ArticleId><ArticleId IdType="pubmed">17636250</ArticleId></ArticleIdList></Reference><Reference><Citation>Gros-Louis F., Kriz J., Kabashi E., McDearmid J., Millecamps S., Urushitani M., Lin L., Dion P., Zhu Q., Drapeau P., et al. Als2 mRNA splicing variants detected in KO mice rescue severe motor dysfunction phenotype in Als2 knock-down zebrafish. Hum. Mol. Genet. 2008;17:2691&#x2013;2702. doi: 10.1093/hmg/ddn171.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddn171</ArticleId><ArticleId IdType="pubmed">18558633</ArticleId></ArticleIdList></Reference><Reference><Citation>Kabashi E., Bercier V., Lissouba A., Liao M., Brustein E., Rouleau G.A., Drapeau P. Fus and tardbp but not sod1 interact in genetic models of amyotrophic lateral sclerosis. PLoS Genet. 2011;7 doi: 10.1371/journal.pgen.1002214.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1002214</ArticleId><ArticleId IdType="pmc">PMC3150442</ArticleId><ArticleId IdType="pubmed">21829392</ArticleId></ArticleIdList></Reference><Reference><Citation>Armstrong G.A.B., Drapeau P. Loss and gain of FUS function impair neuromuscular synaptic transmission in a genetic model of ALS. Hum. Mol. Genet. 2013;22:4282&#x2013;4292. doi: 10.1093/hmg/ddt278.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt278</ArticleId><ArticleId IdType="pubmed">23771027</ArticleId></ArticleIdList></Reference><Reference><Citation>Bourefis A.-R., Campanari M.-L., Buee-Scherrer V., Kabashi E. Functional characterization of a FUS mutant zebrafish line as a novel genetic model for ALS. Neurobiol. Dis. 2020;142 doi: 10.1016/j.nbd.2020.104935.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2020.104935</ArticleId><ArticleId IdType="pubmed">32380281</ArticleId></ArticleIdList></Reference><Reference><Citation>Maselli R.A., Wollman R.L., Leung C., Distad B., Palombi S., Richman D.P., Salazar-Grueso E.F., Roos R.P. Neuromuscular transmission in amyotrophic lateral sclerosis. Muscle Nerve. 1993;16:1193&#x2013;1203. doi: 10.1002/mus.880161109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.880161109</ArticleId><ArticleId IdType="pubmed">8105377</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruneteau G., Simonet T., Bauch&#xe9; S., Mandjee N., Malfatti E., Girard E., Tanguy M.L., Behin A., Khiami F., Sariali E., et al. Muscle histone deacetylase 4 upregulation in amyotrophic lateral sclerosis: Potential role in reinnervation ability and disease progression. Brain. 2013;136:2359&#x2013;2368. doi: 10.1093/brain/awt164.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awt164</ArticleId><ArticleId IdType="pubmed">23824486</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams A.H., Valdez G., Moresi V., Qi X., McAnally J., Elliott J.L., Bassel-Duby R., Sanes J.R., Olson E.N. MicroRNA-206 delays ALS progression and promotes regeneration of neuromuscular synapses in mice. Science. 2009;326:1549&#x2013;1554. doi: 10.1126/science.1181046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1181046</ArticleId><ArticleId IdType="pmc">PMC2796560</ArticleId><ArticleId IdType="pubmed">20007902</ArticleId></ArticleIdList></Reference><Reference><Citation>Pigna E., Renzini A., Greco E., Simonazzi E., Fulle S., Mancinelli R., Moresi V., Adamo S. HDAC4 preserves skeletal muscle structure following long-term denervation by mediating distinct cellular responses. Skelet. Muscle. 2018;8:6. doi: 10.1186/s13395-018-0153-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13395-018-0153-2</ArticleId><ArticleId IdType="pmc">PMC6389241</ArticleId><ArticleId IdType="pubmed">29477142</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang H., Macpherson P., Marvin M., Meadows E., Klein W.H., Yang X.-J.J., Goldman D. A histone deacetylase 4/myogenin positive feedback loop coordinates denervation-dependent gene induction and suppression. Mol. Biol. Cell. 2009;20:1120&#x2013;1131. doi: 10.1091/mbc.e08-07-0759.</Citation><ArticleIdList><ArticleId IdType="doi">10.1091/mbc.e08-07-0759</ArticleId><ArticleId IdType="pmc">PMC2642751</ArticleId><ArticleId IdType="pubmed">19109424</ArticleId></ArticleIdList></Reference><Reference><Citation>Daikoku E., Saito M., Ono F. Zebrafish mutants of the neuromuscular junction: Swimming in the gene pool. J. Physiol. Sci. 2015;65:217&#x2013;221. doi: 10.1007/s12576-015-0372-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12576-015-0372-9</ArticleId><ArticleId IdType="pmc">PMC4408355</ArticleId><ArticleId IdType="pubmed">25782439</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton A.E., Chi&#xf2; A., Traynor B.J. State of play in amyotrophic lateral sclerosis genetics. Nat. Neurosci. 2014;17:17&#x2013;23. doi: 10.1038/nn.3584.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3584</ArticleId><ArticleId IdType="pmc">PMC4544832</ArticleId><ArticleId IdType="pubmed">24369373</ArticleId></ArticleIdList></Reference><Reference><Citation>Lattante S., Rouleau G.A., Kabashi E. TARDBP and FUS Mutations Associated with Amyotrophic Lateral Sclerosis: Summary and Update. Hum. Mutat. 2013;34:812&#x2013;826. doi: 10.1002/humu.22319.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/humu.22319</ArticleId><ArticleId IdType="pubmed">23559573</ArticleId></ArticleIdList></Reference><Reference><Citation>Sorar&#xfa; G., Orsetti V., Buratti E., Baralle F., Cima V., Volpe M., D&#x2019;Ascenzo C., Palmieri A., Koutsikos K., Pegoraro E., et al. TDP-43 in skeletal muscle of patients affected with amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. 2010;11:240&#x2013;243. doi: 10.3109/17482960902810890.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482960902810890</ArticleId><ArticleId IdType="pubmed">19306141</ArticleId></ArticleIdList></Reference><Reference><Citation>Vogler T.O., Wheeler J.R., Nguyen E.D., Hughes M.P., Britson K.A., Lester E., Rao B., Betta N.D., Whitney O.N., Ewachiw T.E., et al. TDP-43 and RNA form amyloid-like myo-granules in regenerating muscle. Nature. 2018;563:508&#x2013;513. doi: 10.1038/s41586-018-0665-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-018-0665-2</ArticleId><ArticleId IdType="pmc">PMC6324568</ArticleId><ArticleId IdType="pubmed">30464263</ArticleId></ArticleIdList></Reference><Reference><Citation>Afroz T., Hock E.M., Ernst P., Foglieni C., Jambeau M., Gilhespy L.A.B., Laferriere F., Maniecka Z., Pl&#xfc;ckthun A., Mittl P., et al. Functional and dynamic polymerization of the ALS-linked protein TDP-43 antagonizes its pathologic aggregation. Nat. Commun. 2017;8:1&#x2013;14. doi: 10.1038/s41467-017-00062-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-00062-0</ArticleId><ArticleId IdType="pmc">PMC5491494</ArticleId><ArticleId IdType="pubmed">28663553</ArticleId></ArticleIdList></Reference><Reference><Citation>Feiguin F., Godena V.K., Romano G., D&#x2019;Ambrogio A., Klima R., Baralle F.E. Depletion of TDP-43 affects Drosophila motoneurons terminal synapsis and locomotive behavior. FEBS Lett. 2009;583:1586&#x2013;1592. doi: 10.1016/j.febslet.2009.04.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.febslet.2009.04.019</ArticleId><ArticleId IdType="pubmed">19379745</ArticleId></ArticleIdList></Reference><Reference><Citation>Silman I., Sussman J.L. Acetylcholinesterase: &#x201c;Classical&#x201d; and &#x201c;non-classical&#x201d; functions and pharmacology. Curr. Opin. Pharmacol. 2005;5:293&#x2013;302. doi: 10.1016/j.coph.2005.01.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coph.2005.01.014</ArticleId><ArticleId IdType="pubmed">15907917</ArticleId></ArticleIdList></Reference><Reference><Citation>Nathan A.J., Scobell A. How China sees America. Foreign Aff. 2012;91 doi: 10.1017/CBO9781107415324.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/CBO9781107415324.004</ArticleId></ArticleIdList></Reference><Reference><Citation>Soreq H. Acetylcholinesterase&#x2014;New roles for an old actor. Nat. Rev. Neurosci. 2001;2:294&#x2013;302. doi: 10.1038/35067589.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/35067589</ArticleId><ArticleId IdType="pubmed">11283752</ArticleId></ArticleIdList></Reference><Reference><Citation>A Owen M.B. Acetylcholine as a Regulator of Neurite Outgrowth and Motility in Cultured Embryonic Mouse Spinal Cord. Neuroreport. 1995;6:22. doi: 10.1097/00001756-199511270-00001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00001756-199511270-00001</ArticleId><ArticleId IdType="pubmed">8747134</ArticleId></ArticleIdList></Reference><Reference><Citation>Small D.H., Reed G., Whitefield B., Nurcombe V. Cholinergic regulation of neurite outgrowth from isolated chick sympathetic neurons in culture. J. Neurosci. 1995;15:144&#x2013;151. doi: 10.1523/JNEUROSCI.15-01-00144.1995.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.15-01-00144.1995</ArticleId><ArticleId IdType="pmc">PMC6578322</ArticleId><ArticleId IdType="pubmed">7823125</ArticleId></ArticleIdList></Reference><Reference><Citation>Lipton S.A., Frosch M.P., Phillips M.D., Tauck D.L., Aizenman E. Nicotinic antagonists enhance process outgrowth by rat retinal ganglion cells in culture. Science. 1988;239:1293&#x2013;1296. doi: 10.1126/science.3344435.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.3344435</ArticleId><ArticleId IdType="pubmed">3344435</ArticleId></ArticleIdList></Reference><Reference><Citation>R&#xfc;diger T., Bolz J. Acetylcholine influences growth cone motility and morphology of developing thalamic axons. Cell Adh. Migr. 2008;2:30&#x2013;37. doi: 10.4161/cam.2.1.5909.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/cam.2.1.5909</ArticleId><ArticleId IdType="pmc">PMC2635000</ArticleId><ArticleId IdType="pubmed">19262162</ArticleId></ArticleIdList></Reference><Reference><Citation>Ichtchenko K., Nguyen T., S&#xfc;dhof T.C. Structures, alternative splicing, and neurexin binding of multiple neuroligins. J. Biol. Chem. 1996;271:2676&#x2013;2682. doi: 10.1074/jbc.271.5.2676.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.271.5.2676</ArticleId><ArticleId IdType="pubmed">8576240</ArticleId></ArticleIdList></Reference><Reference><Citation>Ichtchenko K., Hata Y., Nguyen T., Ullrich B., Missler M., Moomaw C., S&#xfc;dhof T.C. Neuroligin 1: A splice site-specific ligand for &#x3b2;-neurexins. Cell. 1995;81:435&#x2013;443. doi: 10.1016/0092-8674(95)90396-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0092-8674(95)90396-8</ArticleId><ArticleId IdType="pubmed">7736595</ArticleId></ArticleIdList></Reference><Reference><Citation>Constance W.D., Mukherjee A., Fisher Y.E., Pop S., Blanc E., Toyama Y., Williams D.W. Neurexin and neuroligin-based adhesion complexes drive axonal arborisation growth independent of synaptic activity. Elife. 2018;7:1&#x2013;33. doi: 10.7554/eLife.31659.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.31659</ArticleId><ArticleId IdType="pmc">PMC5869020</ArticleId><ArticleId IdType="pubmed">29504935</ArticleId></ArticleIdList></Reference><Reference><Citation>Grifman M., Galyam N., Seidman S., Soreq H. Functional redundancy of acetylcholinesterase and neuroligin in mammalian neuritogenesis. Proc. Natl. Acad. Sci. USA. 1998;95:13935&#x2013;13940. doi: 10.1073/pnas.95.23.13935.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.95.23.13935</ArticleId><ArticleId IdType="pmc">PMC24973</ArticleId><ArticleId IdType="pubmed">9811904</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong H., Xiang Y.Y., Farchi N., Ju W., Wu Y., Chen L., Wang Y., Hochner B., Yang B., Soreq H., et al. Excessive expression of acetylcholinesterase impairs glutamatergic synaptogenesis in hippocampal neurons. J. Neurosci. 2004;24:8950&#x2013;8960. doi: 10.1523/JNEUROSCI.2106-04.2004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.2106-04.2004</ArticleId><ArticleId IdType="pmc">PMC6730061</ArticleId><ArticleId IdType="pubmed">15483114</ArticleId></ArticleIdList></Reference><Reference><Citation>Krejci E., Martinez-Pena Y Valenzuela I., Ameziane R., Akaaboune M. Acetylcholinesterase dynamics at the neuromuscular junction of live animals. J. Biol. Chem. 2006;281:10347&#x2013;10354. doi: 10.1074/jbc.M507502200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M507502200</ArticleId><ArticleId IdType="pubmed">16455662</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J.X., Br&#xe4;nnstr&#xf6;m T., Andersen P.M., Pedrosa-Domell&#xf6;f F. Distinct Changes in Synaptic Protein Composition at Neuromuscular Junctions of Extraocular Muscles versus Limb Muscles of ALS Donors. PLoS ONE. 2013;8 doi: 10.1371/journal.pone.0057473.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0057473</ArticleId><ArticleId IdType="pmc">PMC3582511</ArticleId><ArticleId IdType="pubmed">23468993</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen T.J., Waddell D.S., Barrientos T., Lu Z., Feng G., Cox G.A., Bodine S.C., Yao T.P. The histone deacetylase HDAC4 connects neural activity to muscle transcriptional reprogramming. J. Biol. Chem. 2007;282:33752&#x2013;33759. doi: 10.1074/jbc.M706268200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M706268200</ArticleId><ArticleId IdType="pubmed">17873280</ArticleId></ArticleIdList></Reference><Reference><Citation>Palma E., Reyes-Ruiz J.M., Lopergolo D., Roseti C., Bertollini C., Ruffolo G., Cifelli P., Onesti E., Limatola C., Miledi R., et al. Acetylcholine receptors from human muscle as pharmacological targets for ALS therapy. Proc. Natl. Acad. Sci. USA. 2016;113:3060&#x2013;3065. doi: 10.1073/pnas.1600251113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1600251113</ArticleId><ArticleId IdType="pmc">PMC4801305</ArticleId><ArticleId IdType="pubmed">26929355</ArticleId></ArticleIdList></Reference><Reference><Citation>Polymenidou M., Lagier-Tourenne C., Hutt K.R., Huelga S.C., Moran J., Liang T.Y., Ling S.C., Sun E., Wancewicz E., Mazur C., et al. Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43. Nat. Neurosci. 2011;14:459&#x2013;468. doi: 10.1038/nn.2779.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.2779</ArticleId><ArticleId IdType="pmc">PMC3094729</ArticleId><ArticleId IdType="pubmed">21358643</ArticleId></ArticleIdList></Reference><Reference><Citation>Colombrita C., Onesto E., Megiorni F., Pizzuti A., Baralle F.E., Buratti E., Silani V., Ratti A. TDP-43 and FUS RNA-binding proteins bind distinct sets of cytoplasmic messenger RNAs and differently regulate their post-transcriptional fate in motoneuron-like cells. J. Biol. Chem. 2012;287:15635&#x2013;15647. doi: 10.1074/jbc.M111.333450.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M111.333450</ArticleId><ArticleId IdType="pmc">PMC3346140</ArticleId><ArticleId IdType="pubmed">22427648</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>